Kathrin Schumann

4.7k citations
22 papers · 2.2k indexed · 2 hit papers · h-index 14
Topics
CRISPR and Genetic Engineering (10 papers)CAR-T cell therapy research (7 papers)Immune Cell Function and Interaction (5 papers)

In The Last Decade

Kathrin Schumann

21 papers receiving 2.1k citations

Hit Papers

CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor ...201520262018202220172015100200300400500

Peers

Kathrin Schumann
Comparison fields: 5 of 104
  • Molecular Biology 1.2k
  • Oncology 942
  • Immunology 588
  • Genetics 474
  • Biomedical Engineering 287
Replace Ali Nowrouzi with:
Ali Nowrouzi Germany
Jiing‐Kuan Yee United States
Birgit Dreier Switzerland
Pietro Genovese United States
Melanie Galla Germany
Rasmus O. Bak Denmark
David E. Paschon United States
Shangzhen Zhou United States
Annarita Miccio France
Cynthia C. Bartholomae Germany
Kathrin Schumann relative to Ali Nowrouzi Germany Ali Nowrouzi's profile →
Citations per field
00.5×4.2×
Ali Nowrouzi · 1×
Citations per year

Countries citing papers authored by Kathrin Schumann

Since Specialization
Citations

This map shows the geographic impact of Kathrin Schumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Schumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Schumann more than expected).

Fields of papers citing papers by Kathrin Schumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin Schumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Schumann. The network helps show where Kathrin Schumann may publish in the future.

Co-authorship network of co-authors of Kathrin Schumann

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin Schumann. A scholar is included among the top collaborators of Kathrin Schumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin Schumann. Kathrin Schumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 15
3 9
4 8
5 36
6 115
7 78
8
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cellsbreakdown →
579
9 235
10 131
11 13
12
Generation of knock-in primary human T cells using Cas9 ribonucleoproteinsbreakdown →
533
13 15
14 10
15 5
16 1
17 90
18 210
19
PCR amplification of the phaseolin-genes in 18 species of the genus Phaseolus.
1
20 0

About Kathrin Schumann

Kathrin Schumann is a scholar working on Virology, Immunology and Oncology, having authored 22 papers that have together received 2.2k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (10 papers), CAR-T cell therapy research (7 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Business and International Management (108 citations), Oncology (942 citations) and Virology (148 citations). Kathrin Schumann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Alexander Marson, Chun Ye, Rachel E. Gate, Levi J. Rupp, Kole T. Roybal, Wendell A. Lim, Jennifer A. Doudna, Dimitre R. Simeonov, Steven Lin and Jeffrey A. Bluestone. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026